Lioran Die Passionsblume

Passionflower dry extract, the active ingredient in Lioran Die Passionsblume, is a herbal presented as a dry extract for oral use. It is traditionally used to support calmness and occasional sleep difficulties in adults. GNH USA supplies Lioran Die Passionsblume as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Passionflower dry extract is used as a herbal supplement that may support the nervous system in certain conditions.

Mild anxiety: may help promote a sense of calm. Occasional insomnia: may aid in falling asleep. Restlessness: may reduce subjective feelings of restlessness.

Passionflower dry extract is generally well tolerated, but some users report adverse reactions.

Common Side Effects: - Drowsiness - Dizziness - Headache - Mild gastrointestinal upset - Dry mouth - Light‑headedness

Serious or Rare Side Effects: - Allergic reactions such as rash or urticaria - Severe hypotension - Hepatic injury (rare) - Anaphylaxis - Hallucinations (very rare)

When considering passionflower dry extract, several safety points should be observed. - Pregnancy: safety not established; avoid use unless advised by a healthcare professional. - Breastfeeding: exercise caution as transfer to milk is unknown. - Concurrent CNS depressants: may enhance sedative effects. - Liver disease: use with caution and monitor liver function. - Alcohol: avoid simultaneous consumption to reduce additive sedation. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Passionflower dry extract can interact with other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Benzodiazepines: additive central nervous system depression. - Barbiturates: increased sedation and respiratory depression. - Anticoagulants: potential for enhanced bleeding risk.

Moderate Interactions (Monitor Closely): - Antihistamines: may increase drowsiness. - Selective serotonin reuptake inhibitors (SSRIs): monitor for possible serotonin modulation. - Antidepressants (tricyclics): observe for enhanced sedative effects.